Stockscreener 앱 받기
53.74
1.77%
-0.97
시간 외 거래:
53.74
Bio Techne Corp 주식(TECH)의 최신 뉴스
Ex-Dividend Reminder: Bio-Techne, First Hawaiian and CNA Financial - Nasdaq
Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates - GlobeNewswire Inc.
Bio-Techne's (NASDAQ:TECH) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Stock Analysis | Bio-Techne OutlookBearish Momentum, Weak Technicals, and Mixed Analyst Expectations - AInvest
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know - Yahoo Finance
Bio-Techne's Q4 2025: Navigating Contradictions in NIH Funding, China Growth, and Revenue Outlook - AInvest
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q2 Earnings Call - Yahoo Finance
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - Yahoo Finance
TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty - Yahoo Finance
Bio-Techne Leads Key Proteomic Reagent Markets, but Near-Term Challenges Loom - Morningstar
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls - MSN
Can Bio Techne Corporation disrupt its industryMaximum Leverage Stock Strategy - thegnnews.com
Bio-Techne Corp Q4 Earnings: Revenue Exceeds Estimates at $317M, Adjusted EPS Rises to $0.53, GAAP EPS Misses - AInvest
A Quick Look at Today's Ratings for Bio-Techne(TECH.US), With a Forecast Between $53 to $75 - 富途牛牛
Stocks making big moves yesterday: Bloomin' Brands, Bio-Techne, Snap, Grocery Outlet, and Paramount - Yahoo Finance
A Quick Look at Today's Ratings for Bio-Techne(TECH.US), With a Forecast Between $59 to $65 - 富途牛牛
Bio-Techne Corporation (NASDAQ:TECH) Q4 2025 Earnings Call Transcript - Insider Monkey
Bio-Techne Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Bio-Techne's Q4 Fiscal 2025 Results Trigger 6.5% Share DeclineNews and Statistics - IndexBox
Why Bio-Techne (TECH) Shares Are Plunging Today - Yahoo Finance
Earnings call transcript: Bio-Techne Q4 2025 beats EPS forecasts - Investing.com
Bio-Techne Q2 2025 Financial Results: Revenue and EPS Surpass ExpectationsNews and Statistics - IndexBox
Bio-Techne Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations - Yahoo Finance
Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings - Nasdaq
Bio-Techne Exceeds Forecasts And Refines Its Focus On Growth - Finimize
Bio-Techne Q4 25 Earnings Conference Call At 9:00 AM ET - Nasdaq
Techne (TECH) Beats Q4 Earnings and Revenue Estimates - Nasdaq
Bio-Techne Corp (TECH) Q4 Earnings: Revenue Surpasses Estimates - GuruFocus
Bio-Techne Posts Loss In Q4 - Nasdaq
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Bio-techne declares quarterly dividend of $0.08 per share - Investing.com
Bio-techne declares quarterly dividend of $0.08 per share By Investing.com - Investing.com Canada
Bio-Techne Earnings Beat Estimates as Cell Therapy Division Drives Growth, Strategic Divestiture Announced - Stock Titan
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results06.08.25News - Ariva
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com South Africa
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine - Yahoo Finance
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? - MSN
Will Volume Confirm Reversal in Bio Techne CorporationAI Based High Gain Watchlist Scanner Shared - metal.it
Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow - Yahoo Finance
Why is Bio Techne Corporation stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News
What drives Bio Techne Corporation stock priceExponential wealth increase - Jammu Links News
When is Bio Techne Corporation stock expected to show significant growthGain insights from top financial experts - Jammu Links News
Is Bio Techne Corporation stock overvalued or undervaluedMassive profits - Jammu Links News
How strong is Bio Techne Corporation company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News
Bio Techne Corporation Shows Risk Reward Favoring UpsideAccurate Buy Point for Momentum Stocks Detected - beatles.ru
Is it the right time to buy Bio Techne Corporation stockAI Powered Growth Plan For 2025 - Jammu Links News
Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending - Yahoo Finance
Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns - Yahoo Finance
0.11%
1.56%
자본화:
|
볼륨(24시간):